What does the PregaScreen Quadruple Marker Test include?
Metropolis Healthcare measures AFP, hCG, uE3, and Inhibin-A to assess fetal risk in the second trimester.
How does Metropolis Healthcare perform this test?
The test is processed using advanced serum-based analytical platforms for precise prenatal risk evaluation.
Who should take the Quadruple Marker Test?
Pregnant women between 15–20 weeks may undergo this screening at Metropolis Healthcare for fetal health assessment.
Why is this test important?
It helps estimate the risk of chromosomal or developmental abnormalities with dependable analysis from Metropolis Healthcare.
What sample is required?
A blood sample (serum) is collected at Metropolis Healthcare for evaluating all four markers.
Do I need to prepare before the test?
No special preparation is required; Metropolis Healthcare ensures easy and comfortable sample collection.
Does this test confirm abnormalities?
No, it is a screening test; Metropolis Healthcare may suggest further diagnostic tests if results indicate increased risk.
When will I receive the results?
Metropolis Healthcare provides reports within the standard turnaround time for prenatal screening.